|
[1]
|
Bilusic, M. and Wong, Y.N. (2014) Anti-Angiogenesis in Prostate Cancer: Knocked Down but Not Out. Asian Journal of Andrology, 16, 372-377. [Google Scholar] [CrossRef]
|
|
[2]
|
Bielenberg, D.R. and Zetter, B.R. (2015) The Contribution of Angiogenesis to the Process of Metastasis. Cancer Journal, 21, 267-273. [Google Scholar] [CrossRef]
|
|
[3]
|
Bertz, S., et al. (2014) Increased Angiogenesis and FGFR Protein Ex-pression Indicate a Favourable Prognosis in Bladder Cancer. Virchows Archv, 465, 687-695. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Berretta, M., et al. (2016) Angiogenesis Inhibitors for the Treatment of Hepa-tocellular Carcinoma. Frontiers in Pharmacology, 7, 428. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Yu, P., et al. (2016) Progesterone Modulates Endothelial Progenitor Cell (EPC) Viability through the CXCL12/ CXCR4/PI3K/Akt Signalling Pathway. Cell Proliferation, 49, 48-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Baharara, J., et al. (2014) Anti-Angiogenesis Effect of Biogenic Silver Nanoparticles Synthesized Using Saliva officinalis on Chick Chorioalantoic Membrane (CAM). Molecules, 19, 13498-13508.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Salajegheh, A. (2016) Angiogenesis in Health, Diseases and Malignancy. Springer International Publishing Switzerland. Anticancer Research, 36, 3226. https://www.ncbi.nlm.nih.gov/pubmed/27272869
|
|
[8]
|
Ziebart, T., et al. (2016) Significance of Endothelial Progenitor Cells (EPC) for Tumorigenesis of Head and Neck Squamous Cell Carcinoma (HNSCC): Possible Marker of Tumor Progression and Neo-vascularization? Clinical Oral Investigations, 20, 2293-2300. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Falay, M. and Aktas, S. (2016) Endothelial Progenitor Cells (EPC) Count by Multicolor Flow Cytometry in Healthy Individuals and Diabetes Mellitus (DM) Patients. Clinical Laboratory, 62, 2161-2166.
[Google Scholar] [CrossRef]
|
|
[10]
|
Paynter, R., et al. (2017) Commentary on EPC Methods: An Exploration of the Use of Text-Mining Software in Systematic Reviews. Journal of Clinical Epidemiology, 84, 33-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Altabas, V., Altabas, K. and Kirigin, L. (2016) Endothelial Progenitor Cells (EPCs) in Ageing and Age-Related Diseases: How Currently Available Treatment Modalities Affect EPC Biology, Atherosclerosis, and Cardiovascular Outcomes. Mechanisms of Ageing and Development, 159, 49-62. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wojakowski, W., et al. (2013) Circulating Endothelial Progenitor Cells Are Inversely Correlated with In-Stent Restenosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Treated with EPC-Capture Stents (JACK-EPC Trial). Minerva Cardioangiologica, 61, 301-311.
|
|
[13]
|
Povsic, T.J., et al. (2013) EPC Mobilization after Erythropoietin Treatment in Acute ST-Elevation Myocardial Infarction: the REVEAL EPC Substudy. Journal of Thrombosis and Thrombolysis, 36, 375-383.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yongxiang, W., et al. (2002) Effects of Splenomegaly and Splenic Macrophage Activity in Hypersplenism Due to Cirrhosis. The American Journal of Medicine, 113, 428-431. [Google Scholar] [CrossRef]
|
|
[15]
|
Folkman, J., et al. (1971) Isolation of a Tumor Factor Responsible for Angiogenesis. Journal of Experimental Medicine, 133, 275-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Robinson, K.A., et al. (2016) Twelve Recommendations for Integrating Existing Systematic Reviews into New Reviews: EPC Guidance. Journal of Clinical Epidemiology, 70, 38-44. [Google Scholar] [CrossRef] [PubMed]
|